🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

BB no benefit after AMI with preserved EF !?

Inclisiran is the go-to option for LDL goal w max tolerable Statin

Finally, data to show Impella works !😃

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity dlvr.it/T5dct8

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF dlvr.it/T5h157

Our recent study on sex-specific cardiotoxicity associated with Osimertinib #cardonc Dell Medical School journals.sagepub.com/doi/10.1177/17…

Role of Cardio-Oncology in Breast Cancer Survivorship - truly team work with our patients #cardonc #survivorship #breastcancer Breast Cancer Resource Center (BCRC) bcrc.org/video-resource…

Wow, the way NVIDIA is leading in AI...

📢 New research shows the sex-specific cardiovascular risks associated with #Osimertinib in older patients with #NSCLC. The study reveals increased heart failure risk in women and older adults, urging personalized care. Read more: journals.sagepub.com/doi/full/10.11… UT Austin Yan Liu, MD, PhD, RPVI, FACC

#TCACC2024 from #prevention to #arrhythmias, #myocarditis to #ischemia and #hypertension in ##CardioOncology excellent session by Nicolas Palaskas, MD Efstratios Koutroumpakis, MD Yan Liu, MD, PhD, RPVI, FACC Courtney M. Campbell Alvin Chandra Srilakshmi Vallabhaneni

Rare and beautiful snow in Austin today when the historic STARGATE was announced, a $500 billion massive AI initiative with one of the major focuses on healthcare. Heart disease and cancer treatment were specifically discussed and targeted during the announcement #AI #cardonc

Cannot imagine a better city and better institution to do this #AIhealth#Austin

Jeff Bezos just gave this Longhorn and Eva Longoria Baston $100 million to change the world: utex.as/3WCLkdo #WhatStartsHere

If we want to thoughtfully reduce NIH indirect costs, we need to reduce the federal regulatory burden that causes universities to hire so many administrators to remain compliant.

Longtime visionaries of health & technology Michael Dell 🇺🇸 & John Noseworthy, M.D., forecasted how accelerating innovation & computing capabilities will shape the future of health — led by the new UT Austin Medical Center. See what they shared: bit.ly/40WRxCi

Important work and much needed for our local community Department of Internal Medicine at Dell Med

Presented at #ACC25: In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full trial results:

💥#Warrior trial: no diff in intensive Tx vs usual care in #INOCA PATIENTS #ACC25 #cardiotwitter Janet Wei MD Ana Iribarren, MD #LBCT

Presented at #ACC25: Among older patients undergoing TAVI, dapagliflozin led to a lower incidence of a composite of death from any cause or worsening of heart failure than standard care at 1 year. Full DapaTAVI trial results: nej.md/4kSIc7L Editorial: Aortic Stenosis

Proud of our collaborative work Dell Medical School UT Health Austin Ascension Seton on Cardiovascular Adverse Events and Associated Costs of CDK4/6 Inhibitors in Patients With Breast Cancer doi.org/10.6004/jnccn.…